The Partnership for Safe Medicines India is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from spurious or contraband medicines. For more information, please visit jagograhakjago.com
  
It was heartening to see school children take up the cause of Safe medicines. Just the other day, I was invited as a guest speaker to the children of Oakridge International School, Hyderabad. I was to speak to them on how medicines have become an important cause of diseases and disorders. It was overwhelming to see the ingenious wonders sharing their awareness on medicines as my presentation advanced . If you have any suggestions, comments or queries, please email me at pooja@jagograhakjago.com. Call PSM India toll free helpline 1800 - 11- 4424, to bring cases of spurious medicines or any kind of adverse drug reaction to the notice of the authorities. Happy Reading ! Pooja Khaitan 
|
 Delhi University students 'misuse' non-prescription drugs, study finds
MUMBAI, March 2014: Hefty consultation fees of a doctor and waiting for a long time in a doctor's clinic is what is driving Delhi University students towards adopting self-medication in a big way. A recent study by the Department of Community Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, revealed that frequent advertisements and availability of over-the-counter drugs have made at least 85 per cent DU students, from among those surveyed, pursue self-medication.
 Notice to Asaram centre for selling unlabelled drugs
BANGALORE, March 2014: A centre owned by Sant Shri Asaramji Ashram Trust in the city, run by self-styled spiritual leader Asaram Bapu, is in fresh trouble. The Directorate of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (Ayush) slapped a show-cause notice on its convener.
Maharashtra FDA to take action against companies selling medicines online to overseas clients
MUMBAI, March 2014: In a severe blow to the companies selling drugs online to overseas clients without prescription and a license, Maharashtra FDA will now initiate fresh legal action against two Mumbai-based companies for violation of the Drugs and Cosmetics Act. Such medicines are very expensive and not easily available without a prescription abroad and are purchased over internet from India in violation of Customs Act and Drugs and Cosmetics Act.
 Government exempts antibiotics manufactured before February 28 from labelling provisions of Schedule H1
NEW DELHI, March 2014: The Union health ministry has allowed the chemists to sell antibiotics listed under the Schedule H1, but manufactured before February 28, without the new labelling requirements even as the notification regarding the antibiotics has come into effect from March 1. However, the chemists have been asked to follow other instructions for the sale of these antibiotics with regard to prescription and maintenance of sale records as per the amended rule under the Schedule H1, according to the official sources. Health ministry planning to increase number of New Drug Advisory Committees to 50
NEW DELHI, March 2014: Even as criticism is levelled that the meetings of New Drug Advisory Committees (NDACs) many times did not have the presence of all the experts, the government is planning to raise the number of the NDACs from 12 at present to 50 on a gradual basis. The Central Drugs Standard Control Organisation (CDSCO), pushed by the Parliamentary committee on the functioning of the regulatory mechanism and under pressure from the judiciary, had formed 12 NDACs to advise on matters related to review and regulatory approval of clinical trials and new drugs (except for Investigational New Drugs). Go after inferior drug makers: DCGI
NEW DELHI, March 2014: Faced with criticism internationally over quality of medicines produced in the country, the Drugs Controller-General of India has issued directions for taking prompt and strict action for any violation of quality, safety and efficacy. Drugs Controller-General G.N. Singh has asked the Central Drugs Standard Control Organisation to ensure that drugs, cosmetics and medical devices, manufactured, marketed, imported or exported, meet the quality parameters and safety provisions prescribed under the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945.  Drug Safety Labeling Changes
The summary view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. The “quick view” table below provides the drug name and sections modified. Click on the drug name to go to the detailed view.  Health ministry revokes ban on pain killer drug Analgin
MUMBAI, March 2014: After several months of dilly-dallying on this contentious issue, the Union health ministry has finally revoked the ban on pain-killer drug Analgin, which the ministry had banned on June 18 last year on the plea that the use of Analgin and formulations containing Analgin for human use was likely to involve risk to human beings and safer alternatives to it are available in the market. Maharashtra FDA stops sale of Crocin products for overpricing
MUMBAI, March 2014: The Maharashtra Food and Drug Administration (FDA) has stopped the sale of tablet Crocin Advance, besides two syrups for children - Crocin Drops and Crocin Suspension - saying the products have been overpriced. Crocin Advance contains paracetamol and is a well-established medicine to cure fever and pain. The FDA recently seized stocks worth Rs 12 lakh, saying the prices of these products, manufactured by GlaxoSmithKline, violate the drug price control order.  PLS FIND ENCLOSED LIST OF PRODUCTS DECLAIRED TO BE OF NOT OF STANDARD QUALITY.
YOU ARE REQUESTED TO WITHDRAW SOLD STOCK FROM THE MARKET IN THE INTEREST OF PUBLIC REGARDS S N KALE
|
PSM's 5th annual conference will be held on September 18, 2014 at the KnightConference Center at The Newseum, 555 Pennsylvania Av., NW, Washington, D.C.
jagograhakjago.com; jagograhakjago.com; jagograhakjago.com Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .PSM India may not be held responsible for any article published in PSM NEWZ .